Navigation Links
UTSA, Health Science Center collaborate with Merck & Co. to develop chlamydia vaccine
Date:4/27/2009

San Antonio TX -- The University of Texas at San Antonio (UTSA) and The University of Texas Health Science Center at San Antonio (Health Science Center) today announced an exclusive license and sponsored research agreement with Merck & Co., Inc., to develop a vaccine for chlamydia, targeting the common sexually transmitted bacterium Chlamydia trachomatis.

Under the terms of the agreement with the two University of Texas institutions, Merck will provide funding for research to UTSA and the Health Science Center, whose collaborative team of researchers was the first to demonstrate that, in animal models of genital chlamydial infection, a vaccine composed of a select group of recombinant C. trachomatis antigens can successfully accelerate bacterial clearance, and importantly, preserve female reproductive function. Scientists from Merck and UT will collaborate closely in research directed toward development of an effective chlamydia vaccine.

The Merck license is the first revenue-producing license for any technology developed at UTSA. Upon execution of the license, Merck paid the university an upfront fee, and reimbursed UT for past patent expenses. Going forward, the license is structured to provide payments to the university as vaccine candidates advance through development and are commercialized. Specific financial details were not disclosed. The license is also noteworthy because it is the first exclusive license negotiated and executed by South Texas Technology Management (STTM) for technology shared by two of the four University of Texas System institutions the office serves.

"Inter-institutional partnerships lend themselves to generating interdisciplinary solutions, which in this case is an unmet medical need," said Kenneth Porter, UTSA/Health Science Center assistant vice president for technology transfer and director of STTM. "STTM occupies a unique position among UT institutions and can facilitate the activiti
'/>"/>

Contact: Christi Fish
christi.fish@utsa.edu
830-538-9013
University of Texas at San Antonio
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Study finds blocking angiogenesis signaling from inside cell may lead to serious health problems
2. Youre likely to order more calories at a healthy restaurant
3. UC health news: molecular pathway may predict chemotherapy effectiveness
4. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
5. UCR engineers to develop new tool to measure how environmental exposures affect health
6. Researchers developing device to predict proper light exposure for human health
7. Thousands of starving children could be restored to health with peanut butter program
8. Smithsonian researchers develop models to assess wetland health
9. AIBS to cohost symposium on evolution, disease and human health
10. NASA celebrates a decade observing climate impacts on health of worlds oceans
11. Conference to examine role technology can play in helping US manage healthcare costs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...port published in the December 2009 print issue of...r type of control over their fertility that women ...s have found how and where androgenic hormones wor... and male fertility. This opens a promising avenue...scovery also offers hope to those who cannot have ...
(Date:11/26/2009)... are some of the Ocean,s most distinctive resident...s strange head shape, says Michelle McComb from F... the shark,s vision. ,Perhaps their visual field h...McComb, giving the sharks excellent stereovision a... there were two schools of thought on this theory....
(Date:11/26/2009)...out in eight European countries has shown that clo... pandemic could have a significant role in reducin... open access journal BMC Infectious Diseases com...nd weekends/holidays, finding that they were reduc...elt and Antwerp University, Belgium, led a team of...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2School closure could reduce swine flu transmission by 21 percent 2New stem cell identification technology could cure breast cancer 4969 1New stem cell identification technology could cure breast cancer 4969 2First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 1First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 1ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 3
...eir kind, researchers at Rice University and The U...ve determined that carbon nanotubes injected direc...ause no immediate adverse health effects and circu...d by the liver. , The findings are from the first ...on nanotubes, a revolutionary nanomaterial that ma...
...scoveries are named Charlotte, but they are weavin...studies at Texas A&M University have led to th... one species found for the first time in Texas. , ...dation, Henderson, who is earning a master,s degre...ribution and abundance in the 515-acre Lick Creek ...
... of Warwick should have gardeners and commercial g...ic waste composts. The University,s plant research... paper based composts are proving to be a major we...s. , A University of Warwick research team under ...use of composts can reduce the incidence of some i...
Other Biology News:Pure carbon nanotubes pass first in vivo test 2Ground spider diversity studied in research project 2Recycled paper and compost could both be key tools to control plant disease 2
(Date:11/30/2009)...wswire/ -- Biopharmaceutical company Kiadis,Pharma... enrolled in its,multinational registration clinic...how reduction in transplant related mortality (TRM... transplantation with a mismatched,(haplo-identica...allogeneic,stem cell transplantation but without h...
(Date:11/30/2009)...e-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasd... Administration (FDA) has granted orphan drug desi...ridine phosphate, for the rare autoimmune disease ... has previously received orphan drug designation i...or Medicinal Products for Human Use of the Europea...
(Date:11/30/2009)...swire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a,le...evice research and,development outsourcing company...nnounced that it had been selected to the Deloitte...consecutive year. The list recognizes the 50,faste... and telecommunications,industries based on revenu...
(Date:11/28/2009)...l Advisory Committee on Climate Change (NACCC) thr...ct in collaboration with the Vanuatu Meteorologica...e generated preliminary climate change and sea lev...the country’s SNC reporting to the United Na...CC). , Port Vila, Vanuat...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...n Investment to Finance Growth in Chindex,s Health...ina, BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ --...ding independent American provider of Western,heal...lic of China, today,announced that it has agreed t... Management group. The investment will consist of ...
...., Nov. 7 Transgenomic Inc. (OTC,Bulletin Board: ...Transgenomic Inc. Third Quarter 2007 Earnings Rele...ay, November 7, 2007 @ 5:00 p.m. Eastern, Where: ... How: Live over the Internet -- Simply log on...tact: Investor Relations -- 402-452-5400 To acce...
... CA, Nov. 7 /PRNewswire-FirstCall/ - Nventa,Biopha...y financial results,for the third quarter ended Se...herwise, are in Canadian dollars. Nventa reported...r the,three months ended September 30, 2007, compa...are, for the same period in 2006. For the nine,mon...
Other Biology Technology:JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 2JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 3Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 3Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 4
...dom EVO96R and Freedom EVO384R are fast multi-chan...t, available in three different sizes, with a mult... deliver significant time saving, with true parall...f your assays with the Freedom EVOware program. ...
Bovine Serum, Sterile Filtered from Meridian Life Science, Inc.
Bromophenol Blue sodium salt from Sigma-Aldrich
Blue Magnet from StemCell Technologies, Inc.
Biology Products: